Evidence map›Paper›PMID 35746329›Full record

SynthesisSensors (Basel, Switzerland)2022

Objective Measurement of Walking Activity Using Wearable Technologies in People with Parkinson Disease: A Systematic Review.

Mathias Baptiste Correno, Clint Hansen, Thomas Carlin, Nicolas Vuillerme

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Sensors (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Functional Physical Rehabilitation and Self-Assessment of Physical Activity in Parkinson's Disease.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Mathias Baptiste CorrenoLaboratory AGEIS, Université Grenoble Alpes, 38000 Grenoble, France.ORCID 0000-0002-8383-4224
Clint HansenDepartment of Neurology, Universitätsklinikum Schleswig-Holstein, 24105 Kiel, Germany.ORCID 0000-0003-4813-3868
Thomas CarlinLaboratory AGEIS, Université Grenoble Alpes, 38000 Grenoble, France.ORCID 0000-0001-9058-1723
Nicolas VuillermeLaboratory AGEIS, Université Grenoble Alpes, 38000 Grenoble, France.ORCID 0000-0003-3773-393X
Institut polytechnique de Grenoble · FRUniversity Hospital Schleswig-Holstein · DE

Funding

Agence Nationale de la Recherche ANR-10-AIRT-05 and ANR-15-IDEX-02
6 · The paper itself

Abstract

Parkinson's disease (PD) is a complex neurodegenerative disease with a multitude of disease variations including motor and non-motor symptoms. Quality of life and symptom management may be improved with physical activity. Due to technological advancement, development of small new wearable devices recently emerged and allowed objective measurement of walking activity in daily life. This review was specifically designed to synthesize literature on objective walking activity measurements using wearable devices of patients with PD. Inclusion criteria included patients with a diagnosis of PD and exclusion criteria included studies using animal models or mixed syndromes. Participants were not required to undergo any type of intervention and the studies must have reported at least one output that quantifies daily walking activity. Three databases were systematically searched with no limitation on publication date. Twenty-six studies were eligible and included in the systematic review. The most frequently used device was the ActiGraph GT3X which was used in 10 studies. Duration of monitoring presented a range from 8 h to one year. Nevertheless, 11 studies measured walking activity during a 7-day period. On-body sensor wearing location differed throughout the included studies showing eight positions, with the waist, ankle, and wrist being the most frequently used locations. The main procedures consisted of measurement of walking hours during a 2-day period or more, equipped with a triaxial accelerometer at the dominant hip or ankle. It is also important for further research to take care of different factors such as the population, their pathology, the period, and the environment.

Indexed as

Neurodegenerative DiseasesParkinson DiseaseWearable Electronic DevicesHumansQuality of LifeWalkingmonitoring strategyParkinson’s diseasesystematic reviewwalking activitywearable devices

Identifiers

PMID35746329
PMCPMC9229799
OpenAlexW4283163831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.